Gw Pharma ADR (GWPH) 82.30 $GWPH Zimmer Biomet's LDR

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 11:00 AM

Gw Pharma ADR (GWPH) 82.30 $GWPH

Zimmer Biomet's LDR Buyout On Track, Dental Still a Pain
Zacks Equity Research - Zacks Investment Research - 1 hr 15 mins ago
On Sep 2, 2016, we issued an updated research report on Zimmer Biomet Holdings, Inc. (ZBH).
ZBH: 129.28 (+0.93), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

GNC Holdings Hit by Dismal Q2 Results, Competition Rife
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
GWPH: 82.30 (+0.02), GNC: 20.94 (+0.13), QDEL: 21.72 (-0.02), LNTH: 9.60 (+0.10)

Medtronic Posts Positive Long-term Data for Micra Pacemaker
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:00AM CDT
Medtronic's (MDT) Micra TPS also successfully reduced the risk of patient hospitalization by 47% and risk of system revisions by 82%
MDT: 87.64 (+0.66), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), LNTH: 9.60 (+0.10)

Boston Scientific's Innovation & Emerging Market Raise Hope
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 7:08AM CDT
On Aug 31, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX).
BSX: 24.18 (-0.15), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), LNTH: 9.60 (+0.10)

NuVasive: Strong Q2 Results, Overseas Holds Solid Prospect
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:13AM CDT
NuVasive (NUVA) posted strong results in the second quarter of 2016, with both earnings and revenues squarely beating the Zacks Consensus Estimate
GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), LNTH: 9.60 (+0.10), NUVA: 66.37 (+0.31)

Phibro Animal Health (PAHC) Q4 Earnings Top, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 6:51AM CDT
Phibro's (PAHC) fiscal fourth-quarter bottom line comfortably exceeding the Zacks Consensus Estimate, while its revenues expanded in low-single-digit on a year-over-year basis.
GWPH: 82.30 (+0.02), PAHC: 25.80 (+0.21), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

Medtronic on Track with Covidien Synergy, Buys HeartWare
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 9:02AM CDT
On Aug 26, 2016, we issued an updated research report on Medtronic plc (MDT).
MDT: 87.64 (+0.66), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

Hill-Rom (HRC) Hits New 52-Week High on Solid Q3 Results
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 8:08AM CDT
Shares of Hill-Rom (HRC) rallied to a new 52-week high of $59.45 on Aug 26.
GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31), HRC: 59.84 (+0.59)

Medtronic (MDT) Beats Q1 Earnings, Revenues Closely In-Line
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:29PM CDT
Medtronic plc (MDT)'s reported financial results for first-quarter fiscal 2017. Adjusted earnings per share (EPS) in the reported quarter came in at $1.03, 2 cents ahead of the Zacks Consensus Estimate.
MDT: 87.64 (+0.66), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

TG Therapeutics (TGTX) Catches Eye: Stock Jumps 9.2%
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:00AM CDT
TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares rise over 9% on the day.
GWPH: 82.30 (+0.02), TGTX: 6.51 (unch)

Will GW Pharmaceuticals (GWPH) Crush Estimates at Its Next Earnings Report?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:00AM CDT
GW Pharmaceuticals has a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
GWPH: 82.30 (+0.02)

Medtronic's HeartWare Takeover Complete for $1.1 Billion
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 4:54AM CDT
With HeartWare in its kitty, Medtronic (MDT) will now gracefully lead the global VAD market for heart failure patients.
MDT: 87.64 (+0.66), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), HTWR: 58.20 (+0.22), NUVA: 66.37 (+0.31)

Phibro Animal Health: Currency & Competition Woes Persist
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 3:33PM CDT
Phibro (PAHC) faces competition from generic alternatives of some of its products that may weigh on its future financial health and operational performance.
GWPH: 82.30 (+0.02), PAHC: 25.80 (+0.21), BAX: 46.11 (-0.07), QDEL: 21.72 (-0.02)

The Growth of the Legal and Medical Marijuana Markets
PR Newswire - Tue Aug 23, 8:57AM CDT
The legal marijuana market in the United States is projected to grow substantially in 2016. A recent report by New Frontier and ArcView Market Research projected the marijuana market in the United States to grow to $7.1 billion in 2016, which represents a 26% growth comparing to 2015. Veritas Pharma Inc. (OTC: VRTHF), Cara Therapeutics Inc (NASDAQ: CARA), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech Corp. (TRTC), GW Pharmaceuticals PLC (NASDAQ: GWPH)
CARA: 5.38 (unch), GWPH: 82.30 (+0.02), ZYNE: 8.68 (+0.11)

Illumina Rallies on Rumors of Takeover by Thermo Fisher
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 8:42AM CDT
Reportedly, Thermo Fisher (TMO) has made an all-stock offer of $30 billion to acquire Illumina (ILMN), which currently has a market cap of over $25 billion.
GWPH: 82.30 (+0.02), TMO: 151.03 (+0.08), QDEL: 21.72 (-0.02), ILMN: 169.58 (+1.02)

Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 7:40AM CDT
Cardiovascular Systems Inc. (CSII) saw its shares almost 6% in the last trading session.
CSII: 24.53 (+0.08), GWPH: 82.30 (+0.02)

Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 4:32PM CDT
Insys Therapeutics, Inc. (INSY) announced that it has enrolled the first patient in a phase II trial on its pharmaceutical cannabidiol (CBD) product candidate.
INSY: 14.64 (+0.28), GWPH: 82.30 (+0.02), CORT: 5.32 (-0.03), PCRX: 39.75 (-0.62)

Bruker's Q2 Results Disappoint, Product Launches Continue
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 7:14AM CDT
On Aug 12, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR).
GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), BRKR: 22.33 (-0.11), NUVA: 66.37 (+0.31)

Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:30AM CDT
On Aug 16, 2016, we issued an updated research report on Phibro Animal Health Corporation (PAHC).
GWPH: 82.30 (+0.02), PAHC: 25.80 (+0.21), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 9:27AM CDT
Zimmer Biomet Holdings, Inc. (ZBH) announced the buyout of CD Diagnostics, an immunoassays and biomarker testing developer.
ZBH: 129.28 (+0.93), GWPH: 82.30 (+0.02), QDEL: 21.72 (-0.02), NUVA: 66.37 (+0.31)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Helio Fred Garcia Honored by Diversity Action Alliance

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Woodpack Global Unveils Crate Design System: A New Era Begins

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Maurices Strengthens Position with Key Refinancing Deal

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...